Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Wyden questions Genentech and Eli Lily on hGH

Wyden questions Genentech and Eli Lilly on hGH

WASHINGTON - Rep. Ron Wyden, D-Ore., continuing his investigation of allegations of wrong doing by manufacturers and distributors of human growth hormone, last week sent letters requesting a wide array of information from Genentech Inc. and Eli Lilly and Co.

Wyden, the chairman of the House small business subcommittee on regulation,

Read the full 603 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers